Join to View Full Profile
300 Grand AvenueSuite 101Englewood, NJ 07631
Phone+1 201-567-5787
Fax+1 201-567-7652
Dr. Jan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Louis Jan is a nephrologist based in Englewood, NJ, with extensive training from institutions including the University of Maryland and the Zucker School of Medicine at Hofstra/Northwell. He has expertise in areas such as hypertension, general nephrology, acute renal failure, chronic kidney disease, and transplant nephrology. Dr. Jan has worked as an attending physician at Englewood Health and Holy Name Medical Center since 2003. His research includes a publication on the effects of dexamethasone published in Experimental and Molecular Pathology, and involvement in multiple clinical trials related to kidney disease. His honors include the Jersey Choice Top Doctors award in 2017 and the Castle Connolly Top Doctors award in 2016.
Education & Training
Zucker School of Medicine at Hofstra/NorthwellFellowship, Nephrology, 2001 - 2003
University of MarylandResidency, Internal Medicine, 1996 - 1998- University of MarylandInternship, Internal Medicine, 1995 - 1996
Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1995
University of PennsylvaniaBA, Chemistry, Minor in Oriental Studies, 1987 - 1991
Certifications & Licensure
NJ State Medical License 1998 - 2025
NY State Medical License 1999 - 2004
VA State Medical License 1998 - 2000
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Nephrology
Awards, Honors, & Recognition
- Jersey Choice Top Doctors New Jersey Monthly, 2017
- Castle Connolly Top Doctors 2016
- CMS Meaningful Use Stage 1 Certification Practice Fusion EHR, Practice Fusion, Inc., 2012-2013
- Join now to see all
Clinical Trials
- Correction of Hemoglobin and Outcomes in Renal Insufficiency (CHOIR) Start of enrollment: 2002 Mar 01
- Bone Biopsy Study For Dialysis Patients With Secondary Hyperparathyroidism of End Stage Renal Disease Start of enrollment: 2006 May 01
- A Study to Evaluate PROCRIT (Epoetin Alfa) for Maintenance Phase Treatment of Patients With Anemia Due to Chronic Kidney Disease (PROMPT) Start of enrollment: 2002 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- 6 citationsDexamethasone attenuates oxidation of extracellular matrix proteins by human monocytes.Shahid Ahmed, Ananea Adamidis, Louis C Jan, Nora Gibbons, Joseph Mattana
Experimental and Molecular Pathology. 2003-10-01
Professional Memberships
- Renal Physicians AssociationMember
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
